Segmental stiff skin syndrome treated with secukinumab

Pediatric dermatology(2023)

引用 0|浏览2
暂无评分
摘要
Segmental stiff skin syndrome is a rare fibrosing scleroderma-like disorder characterized by progressive indurations of the skin leading to joint contractures, decreased mobility, and pain. Treatment options are limited; we report a patient that showed improvement with anti-IL17 biologic therapy.
更多
查看译文
关键词
biologic therapy,IL-17,secukinumab,segmental stiff skin syndrome
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要